# A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV

> **NCT06724640** · PHASE1 · RECRUITING · sponsor: **ViiV Healthcare** · enrollment: 168 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** VH4011499 low dose Injection
- **DRUG:** VH4011499 high dose Injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06724640
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-16
- **Primary completion:** 2028-08-16
- **Final completion:** 2028-08-16
- **Target enrollment:** 168 (ESTIMATED)
- **Last updated:** 2025-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06724640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06724640, "A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06724640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*